INTRODUCTION
Depression is a major public health issue worldwide . Projections of the Global Burden of Disease by the WHO suggest that 1 depression will account for 10 of the total disease burden in high-income countries by 2030 . There is fairly consistent evidence that % 2 depression is independently associated with increased risk of mortality . For example, a recent meta-analysis of 25 community studies 3 -7 Despite the large amount of evidence showing depression and RHR to be predictors of mortality, previous studies have not examined the combined impact of depression and RHR. However, in many individuals depression and elevated RHR are co-morbid and it is 14 -16 possible that they exert a combined effect on mortality. Indeed, several studies found clinically depressed psychiatric patients and CHD patients with depression, as compared with their non-depressed counterparts, to have elevated levels of plasma catecholamines and other markers of altered autonomic nervous system (ANS) activity, including elevated heart rate, low heart rate variability, exaggerated heart rate responses to physical stressors . All these indicators of altered ANS function have been found to be associated with increased 14 -20 risks of mortality and cardiac morbidity in patients with CHD . 14 We are aware of no published study that examined mortality risk as a function of both depression status and RHR level. To address this issue, the present study examines the combined effect of depressive symptoms and RHR on mortality in a large cohort of middle-aged British adults.
MATERIAL & METHODS
Data are drawn from the Whitehall II study, established in 1985 as a longitudinal cohort study to examine the socioeconomic gradient in health and disease among 10,308 civil servants (6, study.
Measures

Depressive symptoms
Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D, Cronbach s alpha 0.83) ' = at phase 7 of the Whitehall II study (2002 2004) . The CES-D, a widely used and validated instrument, is a 20-item self-report -questionnaire designed to measure depressive symptomatology in community studies . A score 16 from a total possible score of 60 has 21 ≥ been used extensively to distinguish depressed from nondepressed subjects . 21
Resting Heart Rate RHR was measured at the phase 7 screening clinic via electrocardiogram (ECG) on participants in the supine position following a standard protocol. The following classification was used to categorize RHR: RHR<60, 60 RHR 80, and RHR>80 beats/minute (bpm), ≤ ≥ based on current guidelines that have defined adequate rate control as a ventricular response between 60 and 80 bpm at rest . 22
Vital status
Mortality follow-up was available through the British National Health Services Central Registry until 30 April 2009. Death th certificates were coded using the 10 revision of the International Classification of Disease (ICD). All-cause mortality was the main th outcome in our analysis.
Data on antidepressant medications was drawn from the phase 7 questionnaire where participants were asked whether in the last 14 days they had taken antidepressants drugs prescribed by a doctor (yes/no). CVD medications at phase 7 were also drawn from questions on whether in the last 14 days the participant had taken CVD drugs, including diuretics, beta blockers, ACE inhibitors, calcium channel blockers, nitrates, antiplatelets prescribed by a doctor (yes/no). The same question was used to assess whether participants had taken lipid-lowering medications.
Prevalent Coronary heart disease (CHD)
CHD status at phase 7 was defined as non-fatal myocardial infarction (MI ) or definite angina and was based on clinical examinations 
Statistical analysis
Differences in depression status and RHR categories as a function of the sample characteristics were assessed using a chi-square test.
The associations of depression and RHR with mortality were examined separately using Cox regressions in 4 serially adjusted models. A resting heart rate between 60 80 bpm was used as the reference category so that the hazard ratios (HRs) of lower RHR (< 60 bpm ) and -higher RHR (above 80 bpm) were estimated. In model 1, HRs were adjusted for the following socio-demographic characteristics: sex, age, ethnicity and SEP. Model 2 additionally adjusted the hazard of mortality for smoking, BMI, alcohol consumption, physical activity, hypertension, total blood cholesterol and diabetes. Model 3 was model 1 additionally adjusted for CVD medication (diuretics, beta blockers, ACE inhibitors, calcium channel blockers, nitrates, antiplatelets), antidepressant medication, lipid lowering medication, and history of CHD. Model 4 included all aforementioned variables, depression and RHR categories, in order to estimate their independent effect on mortality.
To examine the combined effect of depression and RHR on mortality, we divided the study sample into six groups based on the cross Cox regressions models were used to calculate multivariable-adjusted risk of death for each group compared with the reference group using the adjustment specified in models 1 and 2 above. The proportional hazards assumption was checked graphically by plotting the log of the negative log of the survival function. These curves were essentially parallel, suggesting therefore that the proportional hazard was not violated.
We also examined the additive interaction between depressive symptoms and elevated RHR as defined by Rothman by calculating 25 the relative excess risk due to interaction (RERI) using the methods outlined by Andersson et al.
. For example, a RERI of 4.0 would 26 27 mean that the relative risk of death from all-causes in depressive participants with elevated RHR is increased by 4.0 compared to the relative risk that one would expect if there were no interaction between these two factors. In the absence of an interaction between depressive symptoms and RHR, the RERI will be 0. Probability values and 95 CIs for the RERI were computed by the delta method .
%
28
RESULTS
A total of 5936 participants were included in the analyses. Of them, 170 died during the mean follow-up period of 5.6 years (SD 0.7, range 0.03 6.6). The mean age of the participants at phase 7, the start of the follow-up for our analysis, was 61 years (SD 6.0). The Table 1 symptoms were more likely to be female, younger, from lower SEP, non-white, on medication (antidepressants, nitrates and antiplatelets), current smokers, less physically active, and to have lower BMI and higher prevalence of diabetes and CHD (all 0.04). Men were more p ≤ likely to have low RHR (<60 bpm, <0.001). Participants with higher RHR (>80 bpm) were more likely to be from lower SEP, less p physically active, hypertensive, obese, diabetic, on CVD medication (beta blockers, nitrates, antiplatelets) and lipid-lowering medication, and to have depressive symptoms (all 0.032). p ≤ Depression, Resting Heart Rate and Mortality J Clin Psychiatry . Author manuscript Page / 4 11 presents estimates from Cox regression models for the associations between depressive symptoms, RHR and mortality. In Table 2 model 1 adjusted for socio-demographic characteristics, depressive participants (CES-D 16) were at increased risk of death (HR 2.46, independently associated with an increased risk of mortality.
shows the associations of combinations of depression status and RHR categories with mortality as the outcome. Model 1, Table 3 adjusted for sociodemographic characteristics, shows that compared with the reference group (participants without depression and with RHR between 60 and 80 bpm), the hazard of death was higher for depressive participants with RHR between 60 and 80 bpm (2.71, 95 CI Although the risk of death seems to be lower among beta blocker users, the small number of deaths among this group precludes any definite conclusions regarding these observations.
DISCUSSION
In this study we sought to examine the combined effect of depressive symptoms and RHR on mortality in a large cohort of British adults. We found that depressive symptoms and elevated RHR were independent predictors for death from all-causes over 5 years of follow up. Concurrently, the study also shows that the coexistence of depression and higher RHR is associated with substantially elevated risk of death from all-causes beyond the effect of having either depression or elevated RHR alone. For instance, after adjustment for relevant biobehavioral risk factors, participants with both depression and RHR >80 bpm were at a 3-fold higher risk of death when compared to those without depression and with RHR ranging from 60 to 80 bpm. This risk is particularly marked in participants with prevalent CHD where there was some evidence of an additive interaction between depressive symptoms and elevated RHR.
Findings in context of the literature and possible mechanisms
To our knowledge, this is the first prospective cohort study to compare the effects of depressive symptoms on mortality in individuals as a function of their RHR. Our findings are based on a large well-characterized cohort with depression symptomatology assessed by a validated scale and biological risk factors assessed by clinical examination. We found that both depression and RHR were strong predictors of death independently of biobehavioral risk factors and of each other. This is consistent with previous studies , , 3 -5 9 -11 Depression, Resting Heart Rate and Mortality J Clin Psychiatry . Author manuscript Page / 5 11 even though these studies usually considered depression and RHR as individual predictors and rarely showed mutually adjusted analyses.
In comparisons across the six exposure categories, we also found that participants with co-existing depression and elevated RHR (>80 bpm) were more likely to die than were participants in any of the other five combinations. Moreover, participants with depression but with RHR ranging from 60 to 80 bpm were at increased risk of mortality compared to those without depression and RHR > 80 bpm, RHR considered to be elevated. These results suggest that the effect of depression on mortality is strong and it is perhaps a stronger predictor of death than RHR in this cohort of middle-aged men and women.
Although this study did not aim to examine the mechanisms that could explain the current observations, several hypotheses seem possible. The finding showing depression to be associated with increased risk of all-cause mortality suggests that depression may act as an exacerbating factor in the progression of other medical illnesses . Although depression is thought to be implicated in the development of 29 certain physical illnesses such as CVD , secondary depression, where a diagnosed or undiagnosed medical illness precedes depression, 30 is also possible. In this case, depression may appear to be a marker of the severity of physical illnesses , . The coexistence of 31 32 depression with other medical illnesses may impair recovery and increase the risk of mortality by impeding treatment seeking, adherence to pharmacological and behavioral regimens, and adoption of healthy life-styles . The association between RHR and mortality is 33 plausible because RHR is a marker of both autonomic nervous system and cardiorespiratory fitness, both of which, when impaired, are associated with the risk of death , . Although an elevated RHR might be the reflection of poor underlying health status , it is 34 35 10
primarily an indicator of cardiorespiratory fitness which is related to physical fitness . Indeed, exercise capacity is a powerful predictor 34 of mortality and RHR is lower in individuals who undertake vigorous physical activity . Depression has been shown to be associated 34 36
with decreased cardiorespiratory fitness which may be the consequence of a lower engagement of individuals in physical activity. Data 37 from the Established Populations Epidemiologic Studies of the Elderly cohort provide some evidence that physical activity is one of the mechanisms underlying the link between depression and physical decline, as those who were depressed undertook less walking, gardening, and vigorous physical activities . This may explain why depression has been found to be associated with high RHR, although 33 depression itself could also affect physical fitness and subsequently RHR levels by directly modulating central nervous system pathways ,
. Furthermore, despite the independent effects observed in this study, high RHR and depression may be associated due to partially 14 38 shared biological processes. Increased RHR in depressive participants could reflect deficits in cardiac vagal control. It is known that cardiac vagal activity when unaltered decreases cardiac activity by reducing RHR and contractility. However, there is also some 39
evidence showing an increased RHR in the absence of reduced vagal tone in depressed patients . Recent studies have shown depression 40 to be associated with low heart rate variability , , an index of reduced cardiac vagal activity, which has been found to be a risk factor 41 42 for all cause and cardiac mortality , . 43 44
Considering the plausibility of the influence of depression on RHR via behavioral and pathophysiological mechanisms and their independent link with mortality, it is highly possible that they exert a combined effect on mortality risk. However, the underlying mechanisms, including the vagal mechanism, behind this association need to be examined in future studies.
Study limitations
In interpreting the present results, it is important to note some limitations. First, this cohort of civil servants did not include blue collar workers, unemployed or younger adults; thus it is not representative of the general population of working age, which may limit the generalisability of our findings. Second, we assessed depressive symptoms rather than clinical depression. However, it has been suggested that significant depressive symptomatology could be a risk factor for clinical depression . Finally, we did not have the power to 21 examine cause specific mortality but the results for all cause mortality are robust. The lack of power may also explain why the confidence interval around the RERI estimating the interaction between depressive symptoms and elevated RHR was large among participants with CHD, but did not reach statistical significance. Although this finding is consistent with the idea that depression and RHR are general rather that specific risk factors of any disease, , further studies should examine whether depression and elevated RHR exert a combined 10 45 effect on CVD, cancer, and non CVD mortality.
Conclusions and implications of this finding
Despite these potential limitations, depression is increasingly recognized to have an important predictive and prognostic value and this study provides additional evidence that the coexistence of depressive symptoms and elevated RHR is associated with substantially increased risk of death. Our findings raise the possibility that treatments that improve both depression and RHR might improve survival.
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